The J.P. Morgan Healthcare Conference: Worth the Fuss?
Attendance is by invitation only. There’s no trade show floor. And, good luck tracking down information on speakers and schedules if you’re not invited — a public website for
Usability: Making Better Websites with Dead Simple User Experience
Let’s get something straight: We’re all marketing to humans. Yes, customers’ perspectives, experiences and industries may differ — even within the life sciences industry. B
Top 10 Biotech IPOs of 2014: West Coast Dominates
What was the most successful biotech IPO of 2014? Look no further than Ultragenyx. A special report by Fierce Biotech says that the Novato, Calif., maker of treatments for rare and
Replacing Adderall: Medicines to Change the World (Part I)
It’s a sad beginning to my series on medications set to change society and the way we live our lives. Shares in the promising biotech Alcobra Pharma plummeted 50 percent this wee
How to Overcome the Life Science Startup Blues
Life science entrepreneurs endure a lot of startup turmoil. First, they face all the usual challenges of understanding the market’s nuances, developing an airtight business model
Marketing With a Magnet, Not a Hammer: Why Biotech Brands Need a Good Digital Strategy
Those in the life science and biotechnology sectors are in a challenging position when trying to attract key audiences to their products, technologies and brands. Thanks to instant
We Hosted Our First Life Science Network UNWIND, Crowd Goes Wild
In November 2011, Chempetitive Group hosted and sponsored the first ever UNWIND happy hour from the Life Science Network in San Diego. Like all good experiments, the event had mult
Thinking Up Something Better: A Front Row Seat for Innovation
We would love to be Einstein’s go-to agency, but time travel isn’t safe yet. Plus, as life science marketers, we have the privilege of working alongside today’s scientists as
The Most Delicious Biotech: Vol. 1
The role of the brewer has always been to optimize the conditions in which biochemical processes occur—in the words of groundbreaking brewing scientist Jean DeClerk, “The yeast
Life-science-finance-a-palooza
One could make an easy argument that the action in San Francisco this week is as good a prognosticator as there is for the financial health of our industry and it will set the tone